Bubeníková-Valesová Vera, Balcar Vladimir J, Tejkalová Hana, Langmeier Milos, St'astný Frantisek
Prague Psychiatric Centre Affiliated with Third Faculty of Medicine & Centre of Neuropsychiatric Studies, 181 03 Prague 8, Czech Republic.
Neurochem Int. 2006 May-Jun;48(6-7):515-22. doi: 10.1016/j.neuint.2006.01.019. Epub 2006 Mar 15.
N-acetyl-L-aspartyl-L-glutamate (NAAG) is a dipeptide that could be considered a sequestered form of L-glutamate. As much as 25% of L-glutamate in brain may be present in the form of NAAG. NAAG is also one of the most abundant neuroactive small molecules in the CNS: it is an agonist at Group II metabotropic glutamate receptors (mGluR II) and, at higher concentrations, at the N-methyl-D-aspartate (NMDA) type of ionotropic glutamate receptors. As such, NAAG can be either neuroprotective or neurotoxic and, in fact, both characteristics have been discussed and described in the literature. In the present studies, 250 nmol NAAG was infused into each lateral cerebral ventricle of 12-day-old rat pups and, using Nissl-stained sections, neurodegeneration in the hippocampus was evaluated 24 or 96 h after the infusion. In several experiments, the neuronal death was also visualised by Fluoro-Jade B staining and studied by TUNEL technique. Some of the NAAG-treated animals were allowed to survive until 50 days post partum and subjected to behavioural (open field) tests. The administration of NAAG to 12-day-old rats resulted in extensive death of neurons particularly in the dentate gyrus of the hippocampus. The neurodegeneration was, in part, prevented by administration of an NMDA receptor antagonist MK-801 (0.1 mg/kg). The nuclear DNA-fragmentation demonstrated by TUNEL technique pointed to the presence of non-specific single-strand DNA cleavage. The NAAG-associated neonatal neuronal damage may have perturbed development of synaptic circuitry during adolescence as indicated by an altered performance of the experimental animals in the open field testing (changes in grooming activity) at postnatal day 50. The results underscore the potential neurotoxicity of NAAG in neonatal rat brain and implicate neonatally induced, NMDA receptor-mediated neuronal loss in the development of abnormal behaviour in young adult rats.
N-乙酰-L-天冬氨酰-L-谷氨酸(NAAG)是一种二肽,可以被认为是L-谷氨酸的一种储存形式。大脑中多达25%的L-谷氨酸可能以NAAG的形式存在。NAAG也是中枢神经系统中最丰富的神经活性小分子之一:它是II组代谢型谷氨酸受体(mGluR II)的激动剂,在较高浓度时,也是离子型谷氨酸受体N-甲基-D-天冬氨酸(NMDA)型的激动剂。因此,NAAG既可以是神经保护剂,也可以是神经毒素,事实上,这两种特性在文献中都有讨论和描述。在本研究中,将250 nmol NAAG注入12日龄大鼠幼崽的每个侧脑室,并使用尼氏染色切片,在注入后24或96小时评估海马体中的神经变性。在几个实验中,还通过Fluoro-Jade B染色观察神经元死亡情况,并通过TUNEL技术进行研究。一些接受NAAG治疗的动物存活至产后50天,并接受行为(旷场)测试。给12日龄大鼠注射NAAG导致神经元大量死亡,尤其是在海马体的齿状回。给予NMDA受体拮抗剂MK-801(0.1 mg/kg)可部分预防神经变性。TUNEL技术显示的核DNA片段化表明存在非特异性单链DNA切割。如实验动物在出生后第50天的旷场测试(梳理活动变化)中表现改变所示,NAAG相关的新生神经元损伤可能扰乱了青春期突触回路的发育。这些结果强调了NAAG在新生大鼠大脑中的潜在神经毒性,并表明新生期诱导的、NMDA受体介导的神经元丢失与年轻成年大鼠异常行为的发展有关。